一般采用Protein A或者Protein G纯化。
靶向: EGF Receptor) Anti-Daratumumab/达雷妥尤单抗 (靶向: CD38) Anti-Denosumab/地舒单抗 (靶向: RANK Ligand) Anti-Dupilumab/度普利尤单抗 (靶向: IL-4Rα) Anti-Durvalumab/度伐利尤单抗 (靶向: CD274) Anti-Eculizumab/依库珠单抗 (靶向: Complement protein
靶向: EGF Receptor) Anti-Daratumumab/达雷妥尤单抗 (靶向: CD38) Anti-Denosumab/地舒单抗 (靶向: RANK Ligand) Anti-Dupilumab/度普利尤单抗 (靶向: IL-4Rα) Anti-Durvalumab/度伐利尤单抗 (靶向: CD274) Anti-Eculizumab/依库珠单抗 (靶向: Complement protein